ONEFUL HEALTH, INC.

Danny has spent the last 20 + years focused on serving patients and physicians with personalized sterile and non-sterile medications for complex needs. As president and operational executive of Triangle Compounding Pharmacy (TCP), the wholly owned compounding pharmacy operation of Oneful, he drove TCP to be the first compounding pharmacy in NC to meet national standards and be accredited by the Pharmacy Compounding Accreditation Board (PCAB). TCP was the first compounding pharmacy in NC to be registered as a Human Drug Outsourcing Facility (503B) to help physicians and hospitals meet critical patient needs by compounding crucial medications during drug shortages. Danny received his Pharm.D. from Campbell University and his Zoology degree at NC State University. As Chief Pharmacy Officer of Oneful Health, he is passionate about implementing cGMP quality robotic automation to modernize compounding pharmacy. His devotion to the highest quality products and services has generated a large, loyal community of patients and healthcare systems. He shares his regulatory and operational expertise through activities with state and national pharmacy organizations. (Fulltime Employee)

Edison is a serial entrepreneur with multiple exits and IPO experience. He is also recognized as a prolific inventor with over 30 patents, spending over 15 years in semiconductor automation in Silicon Valley and the EU. At iRobot Corporation, as Director of Research, he participated on the IPO team and led new business acquisitions and strategic technology roadmap analysis. His engineering and computer science expertise is combined with street-savvy business acumen, having concluded dozens of technology licenses and partnership agreements. He is a lifelong learner and researcher, a Morehead Scholar at the University of North Carolina, an MBA from Duke University, and studied machine learning and robotics at Oxford University U.K., where he spun out his first company. An excellent communicator, he was a speaker at the 2022 Precision Medicine World Conference in Silicon Valley. His passion and vision are that robotics and machine learning can democratize health using low-cost, safe, and more effective personalized treatments. He has assembled a team of experts and operational management that can leverage post-pandemic regulatory change. This team and his inventions are the foundation for a scalable digital health paradigm, economically delivering the benefits of personalized medicine to millions. (Fulltime Employee)

Angela is a CPA, MBA who has served Triangle Compounding Pharmacy (TCP) for 16 years, and led the outside financial review of Oneful and TCP. She was recently appointed to serve as Secretary/Treasure for Oneful Health Inc. She has extensive experience with financial statement preparation, forecasting, payroll, human resource management, benefit planning and implementation, complex problem solving and pharmacy policy development. Certified Public Accountant with 20 years’ experience, MBA, experience with resolving tax issues, audits, business mergers and acquisitions with the related due diligence. BA and MBA from Meredith College. (Fulltime Employee)

Staton has 25 years’ of experience in biotechnology and pharmaceutical research to help create products for individual health and wellness needs. He co-founded and is CEO of Panaceutics Nutrition Inc, a technology leader in personalized and clinical nutrition. As a molecular pharmacologist at Glaxo-Smith Kline, he lead multiple drug discovery projects. He spent five years as Director of the Office of Innovation Commercialization at UNC-Greensboro, managing and licensing intellectual property and negotiating complex interinstitutional agreements. Staton holds a BS in Biochemistry, MS in Gerontology, an MBA, and has authored multiple peered reviewed research articles. (Investor, Outside Advisor)

Andy is Oneful’s senior regulatory and quality consultant, having worked full-time as Vice President of Quality and Regulatory Affairs for the company for 3 years. Formerly on FDA staff with extensive regulatory science expertise and clinical research management experience. Over thirty years as a regulatory consultant for biotech, pharmaceutical, and medical devices. Broad range of regulatory roles at FDA, Abbott, Becton Dickinson, Boston Scientific, Novartis, and Intermountain Healthcare. At St. Jude Children’s Research Hospital, he was the Global Head of Clinical Research and Regulatory Affairs. North Carolina State University, BS Cell Biology. Drexel University College of Medicine, graduate work in Molecular Medicine. (Fractional Contractor)

Bhaskar is President / CEO / Founder of CVenti Chem, a specialized contract drug manufacturer, he is a proven leader with excellent industry knowledge and contacts. As an experienced executive, he also is a scientist with technical knowledge in the custom synthesis of active pharmaceutical ingredients and complex contract pharmaceutical manufacturing processes. His established relationships with key global pharmaceutical supply chains will be a major aid to Oneful. He is a long-time investor in Oneful Health and has invested in many startups. He currently serves on Board of Directors at North Carolina Biotechnology Center and as a Trustee at North Carolina A&T University. PhD in Organic Chemistry, Osmania University, MBA from University of Rochester Simon School. (Investor, Outside Advisor)

Deon represents the Sanitarium Health & Wellbeing Group (AUS), a significant investor in Oneful Health Inc, where he has the role of Executive General Manager - Treasury & Advisory. Sanitarium is one of Australia/New Zealand's largest health food companies, which also operates major hospital facilities there. Deon has responsibility for a range of treasury and finance functions, banking, insurance, legal and M&A. Deon serves as director and/or secretary for most of the Sanitarium Health & Wellbeing Group entities and, as part of the Group’s executive, reports to the Chief Executive Officer. (Outside Board Member)

Garrett is founder of two San Francisco based web platform companies focused on digital health, personalized wellness, and web based healthcare. As Founder-CEO of BioMarker Labs, www.biomarker.io, he created a flexible platform to address the emerging digital health demands. He has demonstrated innovations in software and algorithm development applied to biotechnology, personalized nutrition and telemedicine practices, with current developments demonstrating the use of blockchain to democratize healthcare. Skilled in online enterprise sales, clincal research services, with a science background in molecular & cellular biology. His strong business strategy and digital health expertise makes him an ideal partner for Oneful. Bachelor of Science (BS) focused in Molecular Biology from Duke University. (Fractional Consultant)

Gary is a former Harvard Medical School professor, and an internationally known physician and thought leader on medicine, nutrition, peak performance, and executive health. An advisor to Brigham and Women's Hospital for over twenty years, he has impacted people's lives worldwide with innovations in medicine, notably for the treatments he developed for a rare lung disease that he discovered. He serves startups and private equity-backed companies in roles as medical/surgical clinical consultant and fractional Chief Medical Officer, helping with product development, capital raise, and closing sales. Medical Degrees from Tulane Medical School and in epidemiology at Harvard Channing School of Public Health. (Fractional Consultant)